Reduction of C-reactive protein levels through use of a multivitamin

American Journal of Medicine

Volumn 115, Issue 9, 2003, Pages 702-707

  Church, Timothy S ^a   Earnest, Conrad P ^a   Wood, Kherrin A ^a   Kampert, James B ^a  

^a Cooper Institute ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIBIOTIC AGENT; ASCORBIC ACID; BETA CAROTENE; C REACTIVE PROTEIN; COMPLETE; CYANOCOBALAMIN; FOLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MULTIVITAMIN; PYRIDOXINE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DRUG USE; FEMALE; FROZEN SECTION; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 0348048835     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2003.08.024     Document Type: Article

References (21)

1. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 342:2000;836-843.
2. Ridker P.M., Rifai N., Clearfield M., et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med. 344:2001;1959-1965.
3. Ridker P.M. High-sensitivity C-reactive protein potential adjunct for global risk assessment in the primary prevention of cardiovascular disease . Circulation. 103:2001;1813-1818.
4. Pradhan A.D., Manson J.E., Rifai N., et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 286:2001;327-334.
5. Devaraj S., Jialal I. Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients. Free Radic Biol Med. 29:2000;790-792.
6. Friso S., Jacques P.F., Wilson P.W., et al. Low circulating vitamin B(6) is associated with elevation of the inflammation marker C-reactive protein independently of plasma homocysteine levels. Circulation. 103:2001;2788-2791.
7. Langlois M., Duprez D., Delanghe J., et al. Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation. 103:2001;1863-1868.
8. Earnest CP, Wood K, Church TS. Complex multivitamin supplementation affects homocysteine and LDL-C oxidation. J Am Coll Nutr. 2003;22:400-407.
9. Jilma B., Dirnberger E., Loscher I., et al. Menstrual cycle-associated changes in blood levels of interleukin-6, alpha1 acid glycoprotein, and C-reactive protein. J Lab Clin Med. 130:1997;69-75.
10. Pearson T.A., Blair S.N., Daniels S.R., et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee . Circulation. 106:2002;388-391.
11. Rohde L.E., Hennekens C.H., Ridker P.M. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am J Cardiol. 84:1999;1018-1022.
12. Tamura T., Freeberg L.E., Cornwell P.E. Inhibition of EDTA of growth of Lactobacillus casei in the folate microbiological assay and its reversal by added manganese or iron. Clin Chem. 36:1990;1993.
13. Horne D.W., Patterson D. Lactobacillus casei microbiological assay of folic acid derivatives in 96-well microtiter plates. Clin Chem. 34:1988;2357-2359.
14. Shin Y.S., Rasshofer R., Friedrich B., Endres W. Pyridoxal-5'-phosphate determination by a sensitive micromethod in human blood, urine and tissues its relation to cystathioninuria in neuroblastoma and biliary atresia . Clin Chim Acta. 127:1983;77-85.
15. Stacewicz-Sapuntzakis M., Bowen P., Kendall J., Burgess E. Simulta-neous determination of serum retinal and various carotenoids. J Micronutr Anal. 3:1987;27-45.
16. Thurnham D.I., Davies J.A., Crump B.J., et al. The use of different lipids to express serum tocopherol lipid ratios for the measurement of vitamin E status . Ann Clin Biochem. 23:1986;514-520.
17. Fletcher R.H., Fairfield K.M. Vitamins for chronic disease prevention in adults clinical applications . JAMA. 287:2002;3127-3129.
18. Willett W.C., Stampfer M.J. Clinical practice. What vitamins should I be taking, doctor? N Engl J Med. 345:2001;1819-1824.
19. Routine vitamin supplementation to prevent cancer and cardiovascular disease recommendations and rationale . Ann Intern Med. 139:2003;51-55.
20. Jialal I., Stein D., Balis D., et al. Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels. Circulation. 103:2001;1933-1935.
21. Albert M.A., Danielson E., Rifai N., Ridker P.M. Effect of statin therapy on C-reactive protein levels the Pravastatin Inflammation/CRP Evaluation (PRINCE): a randomized trial and cohort study . JAMA. 286:2001;64-70.